1 / 21

Upper GI Bleed : Clinical Case Presentation

Upper GI Bleed : Clinical Case Presentation. Lisa Philipose 4 / 25/ 06. History. CC: 79 y.o. white male presents via EMS to the Bayview E.D. with two days of loose black tarry stools .

Download Presentation

Upper GI Bleed : Clinical Case Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Upper GI Bleed: Clinical Case Presentation Lisa Philipose 4 / 25/ 06

  2. History • CC: 79 y.o. white male presents via EMS to the Bayview E.D. with two days of loose black tarry stools. • HPI: On the morning PTA, patient felt weak and light-headed, so wife called EMS. VS in the field were: HR:136; BP: 82/48; RR:18; O2sat: 98% on RA; D-stick:150. • 600 cc bolus was administered by EMS and BP increased to 107/61 and HR decreased to 96.

  3. History • ROS: Pt denies N/V/D/C, and denies chest/abdominal/ back/flank/rectal pain. • PMH: HTN, DM, no h/o bleeding d/o; no h/o GI disorders • Last colonoscopy 3 yrs ago reported normal per patient. • PSH: None • Meds: Lisinopril, Metformin, Glucophage, HCTZ, ASA • All: NKDA • SH: No h/o tobacco/alcohol/illicits

  4. Physical • Vital Signs: T: 98.8 HR: 104 RR: 18 BP: 127/89 O2 Sat: 98%, RA • Gen: Pale, smiling, NAD • HEENT: Moist mucus membranes • Lungs: CTAB • CV: RRR, no M/R/G • Abdomen: Nontender, nondistended, +BS • Rectal: Grossly heme positive with black tarry foul smelling stool, one small external hemorrhoid-not ruptured, inflamed, or bleeding • Extremities: No swelling/tenderness, 2+DP pulses • Neuro: Alert and oriented, nonfocal

  5. E.D. course • Two large bore IVs in place- 1L NS bolus followed by NS infusion • Patient placed on O2 and cardiac monitor. • EKG: Normal sinus rhythm • Hemocue: 8.9 g/dl • Labs sent: CBC (hgb=9.4), CMP, T&S, coags, cardiac enzymes • CXR: normal. No free air under diaphragm • Rectal exam grossly positive • NG lavage: 300 cc clear outputNG d/c • Protonix 40mg IV

  6. E.D. course • Orthostatics: • Lying(77, 132/77) • Sitting (73,120/70) • Standing (95,114/62) + pt reports lightheadedness • Repeat CBC (hgb=8.4) and CE • 1 unit PRBCs given • VS stable; • Pt admitted for observation and inpatient endoscopy • GI team aware

  7. Laboratory Data Na: 135 K: 4.5 Cl: 103 CO2: 22 BUN: 77 Cr: 1.6 Glucose: 120 Extended panel: normal WBC: 9310 w/ nl diff Hgb:9.48.4 Hct: 26.524 Platelets:226 Coags: normal Blood Type: A+ CE X 2: negative UA: normal

  8. Differential Diagnosis • Upper GI bleed • Lower GI bleed • Slow bleed from right colon • Bleeding from small bowel • Other causes of black stools: • Iron pills • Licorice • Bismuth (Pepto-Bismol) • Blueberries Melena

  9. Upper GI Bleed • Location: Proximal to ligament of Treitz • Incidence: 100 per 100,000 population • Symptoms: -Melena (70-80%): (>60 ml blood in gut for 8 hrs) -Hematemesis (45-50%) -Presyncope (40%) -Hematochezia (15-20%) -Syncope (15%) *80% bleeds stop spontaneously UGI bleed has 10% mortality

  10. Etiologies of UGI • Peptic ulcer disease (risk factors: HP, NSAIDs, stress, gastric acid) • Esophageal varices • Mallory Weiss-tears • Esophagitis • Gastric/esophageal tumor • Gastritis • Aortoenteric fistula • Lymphoma • Vascular lesions: Dieulafoy, angiodysplasia • Coagulopathy • Anticoagulant use

  11. Approach to UGI Bleed in ED 1.Assess hemodynamic stability (Shock?) - ABC’s 2. Clinical assessment/ Resuscitation (Transfuse?) - 1st use crystalloid, use pRBCs if >2-3L crystalloids needed or signs of ischemia on EKG -O2 -CXR, EKG - Foley, labs - Place NGT: confirm UGI source, assess rapidity of bleeding/ need for endoscopy -involve consultants early if needed -acid suppression therapy (PPI decreases risk of acute rebleed) 3. Risk stratify (Endoscopy? Inpatient or outpatient?) 4. Diagnose

  12. Risk Assessment: ClinicalLancet 2000 • Triage for Outpatient management: Pts with low risk of requiring intervention such as endoscopic therapy or transfusion Factors: -BUN* <6.5 Hgb>13(men), >12 (women) -SBP>110 HR<100

  13. Risk Assessment: Clinical • Triage for Inpatient management: -unknown/suspected variceal bleed -hemodynamic instability -ongoing symptoms of bleeding/ recurrent bleeding -comorbidity req. hospitalization (angina) -mental impairment or noncompliance -coagulopathy -anemia requiring transfusion

  14. Role of Endoscopy Urgent endoscopy generally performed for: -unstable patients, continued bleeding -diagnostic and therapeutic Elective Endoscopy -for stable admitted patients Endoscopic Prognostic Factors (NEJM 1994) Finding Incidence(%) Re-bleed (%) 1.Active bleeding 8 85-100 2.Visible vessel 17-50 18-55 3.Adherent clot 18-26 24-41 4.Dark spots 12-18 5-9 5.Clean-based 10-36 0-1

  15. Non-variceal UGIB:The Controversy of Endoscopic Triage in the ED… *Risk of re-bleeding is difficult to assess clinically Is endoscopic triage a solution? -Perform urgent endoscopy on all patients with acute UGI bleed before admission/triage? better health outcomes? More cost effective? -identify high-risk patients early even if clinically silent -discharge low risk patients

  16. 110 patients :upper GI bleed (nonvariceal) and stable VS randomized *Prospective RCT Early endoscopy in ED *46%(26/56) with low risk lesions d/c’d from ED per GI recs without adverse outcome *8 pts upgraded (wardIMCICU) based on unexpected high risk endoscopic lesions Median LOS: 1 days Median cost: $2,068 Endoscopy within 2 days of admission (control group) Median LOS: 2 days Median cost: $3,662 Assess clinical outcomes and costs prospectively for next 30 days

  17. The other side… -Randomized multicenter trial of nonvariceal UGI bleed (2004) -no difference in LOS or clinical outcomes -difference in study: 40% were recommended for d/c based on endoscopy findings, however only 9% patients actually d/c’d from ED (vs 46% in Lee study) -mimics clinical practice…attending physician admitted patients based on own clinical judgment despite low risk endoscopic results.

  18. Conclusion.. • Endoscopic triage is effective in avoiding hospitalization and reducing costs of low-risk patients • However, if findings of endoscopy do not affect clinical practice by nonendoscopists (ED docs), endoscopic triage is not an effective tool

  19. Back to our patient….Post-ED Course: Patient admitted on a Fridayhad another episode of melena over the weekend Slight drops in hct, managed with fluidsEGD on Tuesday showed: 1) antral erosions 2) healing Mallory Weiss ulcer Pt d/c’d with following recs per GI: -check HP Ab and tx with triple tx if + -continue PPI -outpatient colonoscopy

  20. Summary • Assess hemodynamic stability • Resuscitate • History/physical: risk factors? • Re-assess need for resuscitation often • NG lavage • Endoscopy? • All bleeding stops…eventually

  21. References • Bjorkman DJ. Endoscopic triage for nonvariceal upper gastrointestinal bleeding: the optimal approach in 2001? ASGE wesbite, 2001. • Bjorkman DJ et al., Urgent vs elective endoscopy for acute nonvariceal upper GI bleeding: an effectiveness study. Gastrointest endosc 2004; 60:94-95. • Blatchford O et al., A risk score to predict need for treatment for upper-gastrointestinal hemorrhage. Lancet 2000; 356:1318-21. • Eisen GM et al., Guidelines: An annotated algorithmic approach to gastrointestinal bleeding. Gastro Endo 2001; 53:853. • Jutabha R, Jensen D. Approach to the Adult patient with upper gastro-intestinal bleeding In: UpToDate, Wellesley, MA, 2006. • Laine L, Peterson WL. Bleeding peptic ulcer. NEJM 1994; 331:717-27. • Lee JG, et al., Endoscopy-based traige significantly reduces hospitalization rates and costs of upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999;50:755-61. • Peter DJ and Daughtery JM, Evaluation of the patient with gastrointestinal bleeding: An evidence-based approach. Emerg Med Clin NA 17:239, 1999.

More Related